Health Care & Life Sciences » Biotechnology | QuantRx Biomedical Corp.

QuantRx Biomedical Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4.50
218.50
111.10
0.70
862.60
322
Total Accounts Receivable
120.90
0.40
-
-
-
-
Inventories
2.00
-
-
-
-
-
Other Current Assets
30.20
40.90
26.40
28.10
28.20
37.80
Total Current Assets
157.60
259.80
137.50
28.80
890.80
359.80
Net Property, Plant & Equipment
3.30
2.20
1.10
-
-
-
Total Investments and Advances
200.00
200.00
200.00
169.90
500.00
222
Intangible Assets
37.10
28.50
19.90
13.90
-
-
Total Assets
397.90
490.50
358.50
212.60
1,390.80
581.80
ST Debt & Current Portion LT Debt
738.70
1,156.40
1,312.10
1,658.40
1,945.70
Accounts Payable
285.40
462.30
404.80
-
167.90
Other Current Liabilities
19.70
42.80
34.40
197.00
26.70
Total Current Liabilities
1,043.80
1,661.50
1,751.30
1,855.50
2,140.40
Long-Term Debt
44.00
44.00
39.40
35.60
-
Total Liabilities
1,087.80
1,705.50
1,790.70
1,891.10
2,140.40
Common Equity (Total)
894.00
1,381.70
1,599.00
1,845.30
916.30
Total Shareholders' Equity
689.90
1,214.90
1,432.20
1,678.50
749.60
Total Equity
689.90
1,214.90
1,432.20
1,678.50
749.60
Liabilities & Shareholders' Equity
397.90
490.50
358.50
212.60
1,390.80
Preferred Stock (Carrying Value)
204.20
166.80
166.80
166.80
166.80

About QuantRx Biomedical

View Profile
Address
10190 SW 90th Avenue
Tualatin Oregon 97123
United States
Employees -
Website http://quantrx.com/Overview.htm
Updated 07/08/2019
QuantRx Biomedical Corp. engages in the development and commercializing of patented miniform pads (PAD) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and medical needs. Its platforms include inSync(R), Unique(TM), PadKit(R), and OEM branded over-the-counter and laboratory testing products. The company was founded on December 5, 1986 and is headquartered in Tualatin, OR.